Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 03:20 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Director | Pharmaceutical Preparations | OPT+S | $8.43 | 5,241 | $44,182 | 12,672 | -29.3% |
| 2021-04-06 03:17 | 2021-04-05 | XLRN | N/A | Smith Karen L. | Director | Other | OPT+S | $140.19 | 11,864 | $1,663,156 | 1,622 | -88.0% |
| 2021-04-03 01:00 | 2021-04-01 | XLRN | N/A | Smith Karen L. | Director | Other | OPT+S | $136.47 | 8,925 | $1,218,003 | 4,561 | -66.2% |
| 2016-08-12 23:36 | 2016-08-12 | JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Officer; Global Head of R&D and CMO | Pharmaceutical Preparations | BUY | $137.10 | 608 | $83,356 | 14,182 | +4.5% |
| 2016-07-14 03:09 | 2016-07-13 | JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Officer; Global Head of R&D and CMO | Pharmaceutical Preparations | BUY | $143.63 | 580 | $83,305 | 13,574 | +4.5% |
| 2016-06-16 00:17 | 2016-06-13 | JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Officer; Global Head of R&D and CMO | Pharmaceutical Preparations | BUY | $149.61 | 557 | $83,335 | 12,994 | +4.5% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.